ARK Genomic Revolution ETF (ARKG) ist ein börsennotiertes Unternehmen im Finanzdienstleistungen Sektor, tätig in der Asset Management Branche.
ARKG hat IPO-Datum 2014-10-31, gelistet an der Chicago Board Option, eine Marktkapitalisierung von $1.18B.
ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors that are relevant to the Fund’s investment theme of the genomics revolution.
